Webinar
Drafting Claims to Survive Hatch-Waxman Litigation
Hosts
-
- Name
- Person title
- Principal
-
- Name
- Person title
- Principal
-
- Name
- Person title
- Principal
Enacted by Congress in 1984, the Hatch-Waxman Act balances the need for lower-cost prescription drugs and the protection of pharmaceutical innovations. While Hatch-Waxman litigation does not officially begin until the patent owner sues, success in Hatch-Waxman litigation begins well before that point. It is therefore important for pharmaceutical companies to consider the possibility of future Hatch-Waxman litigation when drafting their patent claims.
On August 9, join Principals Gwilym Attwell, Nitika Fiorella, and Michael Kane for an overview of Hatch-Waxman litigation, as well as claim-drafting tips to:
- Simplify infringement proof
- Minimize susceptibility to prior art validity attacks
- Avoid adverse § 112 findings
Download a copy of the webinar slides.
If you have any questions, please contact [email protected].